Some analytical functions were tested for goodness of fit to standard curves in radio-immunoassays of insulin (Hales & Randle, 1963) . Letting a, b and c be parameters, and y the radioactivity measured at an insulin concentration of x, excellent fit was obtained with the function 1/(y+c) = ax+b. This function was associated with a smaller variance around y and a greater number of sign changes for the residuals (calculated radioactivity minus observed radioactivity) than any of the following: 1/y = axc +b; y-ebx+c. y -a±bX+c2 +dX3. The meannumber of sign changes of the residuals in 50 separate assays of mouse insulin was within the 95% confidence interval expected for a correct model. The function that was found to be applicable to assays ofmouse, human and ox insulins should be useful in routines for computer processing of insulin assay data and may also prove applicable to other radio-immunoassays.
Some analytical functions were tested for goodness of fit to standard curves in radio-immunoassays of insulin (Hales & Randle, 1963) . Letting a, b and c be parameters, and y the radioactivity measured at an insulin concentration of x, excellent fit was obtained with the function 1/(y+c) = ax+b. This function was associated with a smaller variance around y and a greater number of sign changes for the residuals (calculated radioactivity minus observed radioactivity) than any of the following: 1/y = axc +b; y-ebx+c. y -a±bX+c2 +dX3. The meannumber of sign changes of the residuals in 50 separate assays of mouse insulin was within the 95% confidence interval expected for a correct model. The function that was found to be applicable to assays ofmouse, human and ox insulins should be useful in routines for computer processing of insulin assay data and may also prove applicable to other radio-immunoassays.
Because of their simplicity and accuracy, radio. immunoassays for the measurement of insulin have become indispensable in diabetes research. Since modem diagnostic principles in the care of diabetic patients require measurements of insulin in plasma, such assays are today widely used not only in experimental laboratories but also in clinics. The routine of insulin measurements should be considerably facilitated by computer processing of the radioisotope data. A programme for use in combination with the double-antibody technique has been presented by Morgan, Hardigg & Fisher (1967) , who suggested a semilogarithmic transformation to rectify the standard curve. Although this approach may be useful as a first approximation, it is associated with systematic errors that considerably limit the practical range of the assay. A more accurate knowledge of the mathematical function that applies to the standard curve is therefore desirable. This problem has been theoretically considered by Hales & Randle (1963) , Berson & Yalow (1968) , Rodbard, Rayford, Cooper & Ross (1968) and Rodbard, Bridson & Rayford (1969) . Possible limitations of theory make it necessary, however, to approach the problem of curve-fitting by systematic analyses of empirical data. In the present study a great number of standard curves, obtained with a widely used version of the double-antibody assay (Hales & Randle, 1963) , have been analysed by testing their fit to some analytical functions.
MATERIALS AND METHODS
Insulin was assayed by the double-antibody radioimmunoassay described as 'Method C' by Hales & Randle (1963) . 125I-labelled ox insulin, insulin-binding reagent (a mixture of guinea-pig antiserum against pig insulin and rabbit antiserum against guinea-pig y-globulin) and crystalline human insulin were purchased from The Radiochemical Centre, Amersham, Bucks., U.K. Crystalline mouse insulin was prepared by Novo Industri, Copenhagen, Denmark, and crystalline ox insulin was obtained from Vitrum, Stockholm, Sweden. We analysed 50 mouse insulin standard curves that had been used in routine assays during 1969. All these curves were based on 18 points representing triplicate determinations of the following insulin concentrations: 0, 1.25, 2.5, 5.0, 10.0 and 20.Ong/ml. Since the curves were collected during a whole year, several batches of labelled insulin and insulinbinding reagent were used. In addition, a few standard curves comprising 33 points (triplicate determinations at insulin concentrations of 0, 1. 25, 2.5, 5.0, 7.5, 10.0, 12.5, 15.0, 20.0, 30 .0 and 40.0ng/ml) were prepared with mouse, ox and human insulins. In each assay correction was made for non-specific adsorption of radioactivity to the membrane filter.
Letting a, b, c and d be parameters and y be the radioactivity obtained with a concentration x of unlabelled insulin, the following functions were tested for goodness of fit to the experimental data: l/y= ax+b l(y+c) = ax+b y= bx + c y = a + bx±+cx2 y = a+bx+ cX2 + dx3
Since y, and not l/y, was observed in the assays, functions (1963) . Its fit to the data is shown in Fig. 1 . It is I and II were fitted to data and numerically analysed in clear from inspection that plotting radioactivity-' the following rewritten forms:
versus insulin concentration does not produce a y = c/(x + y) (function I) straight line, and that the deviation from function I y = (ax+ P)/(x+ y) (function II) appears to be most pronounced at high insulin concentrations. This is in accordance with the Functions of the form y = In x+b (cf. Morgan et al. 1967 ) failure of Hales & Randle (1963) to demonstrate a were not tested, since they predict lim +o y = -o a con-linear relationship for insulin concentrations exdition that obviously does not apply to the insulin ceeding a certain value. standard curves.
The actrtat fue.
In the treatment of functions I and II, the correct
The fact that function I was found to be associparameter values were approached in a stepwise manner. ated with a systematic error, which makes its use In each step y was fixed and provisional values of a and p in a computer routine undesirable, initiated the were computed by using the method of least squares. The study of the other analytical functions. One of procedure was repeated for new values of y until minimum these, function II, was tested because a great many variance was obtained. Function III was fitted to data by plots of radioactivity versus insulin concentration the non-linear iterative method of Gauss (Moore & gave the impression that the standard curve apZeigler, 1958), whereas ordinary multiple regression proached an asymptote parallel with the abscissa. analysis was applied to functions IV and V. Goodness of Functions III-V were analysed for comparison, fit was estimated with the aid of two statistical parameters, namely the variance and the number of sign changes for since they represent commonly used approximathe residuals (calculated radioactivity minus observed tions in non-linear fitting of experimental data. radioactivity) around the computed functions. All Table 1 summarizes the analysis of results obcomputations were performed on a Control Data Corpora-tained in 50 different assays of mouse insulin. tion 3200 digital computer.
Fitting of function II to these data yielded a variance that was lower than those obtained with the RESULTS AND DISCUSSION other functions, the differences being statistically Conen. of unlabelled insulin (ng/ml) (x) Fig. 2 . The same experimental data as illustrated in Fig. 1 are shown. In this case the points have been fitted by function II and the resulting curves are indicated in the main diagrams, which also show the computed asymptotes y = c(----). The insets show plots of (observed radioactivity minus c)-' versus insulin concentration and the corresponding representations of the computed curves. Comparison with Fig.  1 shows that function II gives a much better fit than function I. than with any of the other functions. The mean number of sign changes calculated for function II, 8.86 , is, in fact, within the 95% confidence interval, 8.40-9.60, that would be expected for a correct model because of random variations in 50 curves consisting of 18 points each. This means not only that function II is better than the other functions tested, but also that it could not be distinguished from correctness on the basis of the present data. Fig. 2 illustrates its fit to the same experimental results as used in Fig. 1 . It further appears from Table 1 that function I was less well fitted to the data than function III (P<0.05) and not significantly better than function V.
Although the above results appear to be quite clear-cut, their value would be somewhat limited unless they could be shown to apply to assays of human insulin. The fact that I 25I-labelled ox insulin was used in the assays made it desirable to analyse ox insulin standard curves also. Table 2 It has been suggested by Rodbard et al. (1968 Rodbard et al. ( , 1969 that the function y = af(x"+b) gives an adequate description of many different kixnds of radio-immunoassay standard curves. This function has not been included in the above comparison since it is computationally quite difficult to handle in its explicit form. Its fit to the 50 mouse insulin standard curves has, however, been tested in the form l/y = ,cx+fl (function VI). Although this approach precludes the use of residual variance in a direct comparison with the other functions, the powerful test of residual sign changes (Chakravarti, Laha & Roy, 1967 ) is still valid. Function VI was associated with 7.880±0.324 residual sign changes, which means a significantly (P<0.01) worse fit than that obtained with function II. In fact, the fit of function VI was not better than that of function V.
Methodological conserations. It appears to be a common characteristic of radio-immunoassays that the variance of points on the standard curve is not homogeneous. This introduces a statistical problem in least-square fitting of data, which is aggravated if linearization of the standard curve is attempted by means of logit transformation (Rodbard et al. 1968) . was rather small throughout the standard curve.
Since, in addition, the non-homogeneity was moderate, it was decided to attribute equal weights to all points. This proved to be a successful strategy. Function II, which was not arrived at by theoretical deduction but chosen for testing because of its analytical properties, showed an excellent fit to the experimental data. In fact, it was indistinguishable from a correct model as regards the number of residual sign changes (cf. Chakravarti et al. 1967) . Further, the absolute error of points about the standard curve (the residuals) was of the same order as the variance of experimental data at all insulin concentrations (Table 3 ). The small variation from experiment to experiment of the estimated parameters a, b and c is illustrated in Table 4 . The characteristic feature of function II as compared with function I is the asymptote, y = c, in a plot of radioactivity versus insulin concentration. This asymptote makes possible a correction for a fraction of the precipitated radioactivity that remains constant within each assay. It is not quite clear why such a correction is necessary. One obvious possibility is that some of the radioactive material remained unspecifically adsorbed to the immunoprecipitate in spite of the thorough washing that was regularly performed. An explanation must, however, take into account not only that function II was better than function I with all insulins tested, but also that the distance of the asymptote from the abscissa appeared greater with mouse insulin than with human and ox insulins. Such a species difference is probably due to the immunological properties of the various insulins. It would, for example, be expected if the preparation of antibodies used contained two reactive sites, both being capable ofbindinghuman and ox insulins, but only one of which reacted effectively with mouse insulin.
Whatever the nature of the underlying mechanisms, it can be concluded that function II should be ideally suited for routine use in computer processing of the radio-isotope data obtained in double-antibody assays of insulin. It remains to be seen whether it will also prove useful in assays utilizing other principles for the isolation of the antibody-bound insulin and in assays of other hormones. At present it seems reasonable to assume that it may have a rather general applicability. This work was financially supported by the U.S. Public Health Service (AM-12535), the Swedish Medical Research Council (12x-2288) and the Swedish Natural Science Research Council. The skilful technical assistance of Miss Karin Janze is gratefully acknowledged.
